Citations (38)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Christian Huisman, Monique GP van der Wijst, Fahimeh Falahi, Juul Overkamp, Gellért Karsten, Martijn M Terpstra, Klaas Kok, Ate GJ van der Zee, Ed Schuuring, G Bea A Wisman & Marianne G Rots. (2015) Prolonged re-expression of the hypermethylated gene EPB41L3 using artificial transcription factors and epigenetic drugs. Epigenetics 10:5, pages 384-396.
Read now
Read now
M Ian Phillips & Andrew B Burns. (2014) The emergence of gene therapy for rare diseases. Expert Opinion on Orphan Drugs 2:11, pages 1197-1209.
Read now
Read now
Articles from other publishers (36)
Ngo Hoang Long & Sook-Jeong Lee. (2023) Targeting casein kinase 1 for cancer therapy: current strategies and future perspectives. Frontiers in Oncology 13.
Crossref
Crossref
Hunter Levis, Jacob Weston, Brooke Austin, Bryce Larsen, Matthew Ginley-Hidinger, Sarah E. Gullbrand, Brandon Lawrence & Robby D. Bowles. (2023) Multiplex gene editing to promote cell survival using low-pH clustered regularly interspaced short palindromic repeats activation (CRISPRa) gene perturbation. Cytotherapy 25:10, pages 1069-1079.
Crossref
Crossref
Rachel Dennison, Esteban Usuga, Harriet Chen, Jacob Z. Paul, Christian A. Arbelaez & Yang D. Teng. (2023) Direct Cell Reprogramming and Phenotypic Conversion: An Analysis of Experimental Attempts to Transform Astrocytes into Neurons in Adult Animals. Cells 12:4, pages 618.
Crossref
Crossref
Elvir Becirovic. (2022) Maybe you can turn me on: CRISPRa-based strategies for therapeutic applications. Cellular and Molecular Life Sciences 79:2.
Crossref
Crossref
Jules J. Berman. 2022. Classification Made Relevant. Classification Made Relevant
251
341
.
Jose L. Gerardo Nava, Jonas C. Rose, Haktan Altinova, Paul D. Dalton, Laura De Laporte & Gary A. Brook. 2021. Nanomedicines for Brain Drug Delivery. Nanomedicines for Brain Drug Delivery
61
101
.
Giulio Chiesa, Szilvia Kiriakov & Ahmad S. Khalil. (2020) Protein assembly systems in natural and synthetic biology. BMC Biology 18:1.
Crossref
Crossref
Niloofar FarhangBryton DavisJacob WestonMatthew Ginley-HidingerJason GertzRobby D. Bowles. (2020) Synergistic CRISPRa-Regulated Chondrogenic Extracellular Matrix Deposition Without Exogenous Growth Factors. Tissue Engineering Part A 26:21-22, pages 1169-1179.
Crossref
Crossref
Jules J. Berman. 2020. Logic and Critical Thinking in the Biomedical Sciences. Logic and Critical Thinking in the Biomedical Sciences
187
208
.
Kuldeep Rajpoot, Maliheh Safavi, Nagaraja Sreeharsha & Rakesh K. Tekade. 2020. The Future of Pharmaceutical Product Development and Research. The Future of Pharmaceutical Product Development and Research
367
412
.
Alexander Brown, Jackson Winter, Michael Gapinske, Nathan Tague, Wendy S Woods & Pablo Perez-Pinera. (2019) Multiplexed and tunable transcriptional activation by promoter insertion using nuclease-assisted vector integration. Nucleic Acids Research 47:12, pages e67-e67.
Crossref
Crossref
Bryan Zeitler, Steven Froelich, Kimberly Marlen, David A Shivak, Qi Yu, Davis Li, Jocelynn R Pearl, Jeffrey C Miller, Lei Zhang, David E Paschon, Sarah J Hinkley, Irina Ankoudinova, Stephen Lam, Dmitry Guschin, Lexi Kopan, Jennifer M Cherone, Hoang-Oanh B Nguyen, Guijuan Qiao, Yasaman Ataei, Matthew C Mendel, Rainier Amora, Richard Surosky, Josee Laganiere, B Joseph Vu, Anand Narayanan, Yalda Sedaghat, Karsten Tillack, Christina Thiede, Annette Gärtner, Seung Kwak, Jonathan Bard, Ladislav Mrzljak, Larry Park, Taneli Heikkinen, Kimmo K Lehtimäki, Marie M Svedberg, Jenny Häggkvist, Lenke Tari, Miklós Tóth, Andrea Varrone, Christer Halldin, Andrea E Kudwa, Sylvie Ramboz, Michelle Day, Jyothisri Kondapalli, D James Surmeier, Fyodor D Urnov, Philip D Gregory, Edward J Rebar, Ignacio Muñoz-Sanjuán & H Steve Zhang. (2019) Allele-selective transcriptional repression of mutant HTT for the treatment of Huntington’s disease. Nature Medicine 25:7, pages 1131-1142.
Crossref
Crossref
Valentin Baumann, Maximilian Wiesbeck, Christopher T. Breunig, Julia M. Braun, Anna Köferle, Jovica Ninkovic, Magdalena Götz & Stefan H. Stricker. (2019) Targeted removal of epigenetic barriers during transcriptional reprogramming. Nature Communications 10:1.
Crossref
Crossref
Jules J. Berman. 2019. Taxonomic Guide to Infectious Diseases. Taxonomic Guide to Infectious Diseases
19
37
.
Jules J. Berman. 2019. Evolution's Clinical Guidebook. Evolution's Clinical Guidebook
239
283
.
Jules J. Berman. 2019. Evolution's Clinical Guidebook. Evolution's Clinical Guidebook
145
171
.
Matthew Gemberling & Charles A. Gersbach. (2018) Boosting, Not Breaking: CRISPR Activators Treat Disease Models. Molecular Therapy 26:2, pages 334-336.
Crossref
Crossref
Ci-Di Chen, Ella Zeldich, Yuexuan Li, Andrea Yuste & Carmela R. Abraham. (2018) Activation of the Anti-Aging and Cognition-Enhancing Gene Klotho by CRISPR-dCas9 Transcriptional Effector Complex. Journal of Molecular Neuroscience 64:2, pages 175-184.
Crossref
Crossref
Tobias Anton, Elisabeth Karg & Sebastian Bultmann. (2018) Applications of the CRISPR/Cas system beyond gene editing. Biology Methods and Protocols 3:1.
Crossref
Crossref
Jules J. Berman. 2018. Precision Medicine and the Reinvention of Human Disease. Precision Medicine and the Reinvention of Human Disease
327
365
.
Anne-Sophie Gautron, Alexandre Juillerat, Valérie Guyot, Jean-Marie Filhol, Emilie Dessez, Aymeric Duclert, Philippe Duchateau & Laurent Poirot. (2017) Fine and Predictable Tuning of TALEN Gene Editing Targeting for Improved T Cell Adoptive Immunotherapy. Molecular Therapy - Nucleic Acids 9, pages 312-321.
Crossref
Crossref
Nixon Niyonzima, Abigail R. Lambert, Rachel Werther, Harshana De Silva Feelixge, Pavitra Roychoudhury, Alexander L. Greninger, Daniel Stone, Barry L. Stoddard & Keith R. Jerome. (2017) Tuning DNA binding affinity and cleavage specificity of an engineered gene-targeting nuclease via surface display, flow cytometry and cellular analyses. Protein Engineering, Design and Selection 30:7, pages 503-522.
Crossref
Crossref
Joshua B. Black, Pablo Perez-Pinera & Charles A. Gersbach. (2017) Mammalian Synthetic Biology: Engineering Biological Systems. Annual Review of Biomedical Engineering 19:1, pages 249-277.
Crossref
Crossref
Alexander Brown, Wendy S. Woods & Pablo Perez-Pinera. 2017. Enhancer RNAs. Enhancer RNAs
235
250
.
Manjunath N. Swamy, Haoquan Wu & Premlata Shankar. (2016) Recent advances in RNAi-based strategies for therapy and prevention of HIV-1/AIDS. Advanced Drug Delivery Reviews 103, pages 174-186.
Crossref
Crossref
Elena Matsa, John H. Ahrens & Joseph C. Wu. (2016) Human Induced Pluripotent Stem Cells as a Platform for Personalized and Precision Cardiovascular Medicine. Physiological Reviews 96:3, pages 1093-1126.
Crossref
Crossref
J G Choi, Y Dang, S Abraham, H Ma, J Zhang, H Guo, Y Cai, J G Mikkelsen, H Wu, P Shankar & N Manjunath. (2016) Lentivirus pre-packed with Cas9 protein for safer gene editing. Gene Therapy 23:7, pages 627-633.
Crossref
Crossref
C A Giménez, M Ielpi, A Mutto, L Grosembacher, P Argibay & F Pereyra-Bonnet. (2016) CRISPR-on system for the activation of the endogenous human INS gene. Gene Therapy 23:6, pages 543-547.
Crossref
Crossref
Joshua Hunsberger, Josh Neubert, Jason A. Wertheim, Julie Allickson & Anthony Atala. (2016) Bioengineering Priorities on a Path to Ending Organ Shortage. Current Stem Cell Reports 2:2, pages 118-127.
Crossref
Crossref
Hannah Pham, Nicola A. Kearns & René Maehr. 2016. Post-Transcriptional Gene Regulation. Post-Transcriptional Gene Regulation
43
57
.
M Sachdeva, N Sachdeva, M Pal, N Gupta, I A Khan, M Majumdar & A Tiwari. (2015) CRISPR/Cas9: molecular tool for gene therapy to target genome and epigenome in the treatment of lung cancer. Cancer Gene Therapy 22:11, pages 509-517.
Crossref
Crossref
Lauren R. Polstein, Pablo Perez-Pinera, D. Dewran Kocak, Christopher M. Vockley, Peggy Bledsoe, Lingyun Song, Alexias Safi, Gregory E. Crawford, Timothy E. Reddy & Charles A. Gersbach. (2015) Genome-wide specificity of DNA binding, gene regulation, and chromatin remodeling by TALE- and CRISPR/Cas9-based transcriptional activators. Genome Research 25:8, pages 1158-1169.
Crossref
Crossref
Monique G.P. van der Wijst, Christian Huisman, Archibold Mposhi, Gerard Roelfes & Marianne G. Rots. (2015) Targeting Nrf2 in healthy and malignant ovarian epithelial cells: Protection versus promotion. Molecular Oncology 9:7, pages 1259-1273.
Crossref
Crossref
Ami M. Kabadi, Pratiksha I. Thakore, Christopher M. Vockley, David G. Ousterout, Tyler M. Gibson, Farshid Guilak, Timothy E. Reddy & Charles A. Gersbach. (2014) Enhanced MyoD-Induced Transdifferentiation to a Myogenic Lineage by Fusion to a Potent Transactivation Domain. ACS Synthetic Biology 4:6, pages 689-699.
Crossref
Crossref
Alexandre Juillerat, Coline Pessereau, Gwendoline Dubois, Valérie Guyot, Alan Maréchal, Julien Valton, Fayza Daboussi, Laurent Poirot, Aymeric Duclert & Philippe Duchateau. (2015) Optimized tuning of TALEN specificity using non-conventional RVDs. Scientific Reports 5:1.
Crossref
Crossref
Ami M. Kabadi, David G. Ousterout, Isaac B. Hilton & Charles A. Gersbach. (2014) Multiplex CRISPR/Cas9-based genome engineering from a single lentiviral vector. Nucleic Acids Research 42:19, pages e147-e147.
Crossref
Crossref